Design of novel cyclic altered peptide ligands of myelin basic protein MBP(83-99) that modulate immune responses in SJL/J mice

The use of antagonist peptides derived from the myelin sheath constitutes a promising therapeutic approach for multiple sclerosis (MS). Cyclization of peptide analogues is of great interest, since the limited stability of linear peptides restricts their potential as therapeutic agents. Herein, we de...

Full description

Saved in:
Bibliographic Details
Published inJournal of medicinal chemistry Vol. 51; no. 13; pp. 3971 - 3978
Main Authors Katsara, Maria, Deraos, George, Tselios, Theodore, Matsoukas, John, Apostolopoulos, Vasso
Format Journal Article
LanguageEnglish
Published WASHINGTON Amer Chemical Soc 10.07.2008
Subjects
Online AccessGet full text

Cover

Loading…